InMode, the Israeli energy-device manufacturer known for its fractional RF microneedling (Morpheus8) and radiofrequency platforms, received an unsolicited takeover proposal. While the bidder's identity and offer terms remain undisclosed, the move signals intensifying consolidation pressure in the aesthetic device market as larger players and PE firms seek to consolidate fragmented RF and laser portfolios.
Business & M&A
InMode Receives Unsolicited Takeover Offer — Consolidation Pressure Mounts in Energy-Device Space
PE or strategic buyer circles InMode; device M&A cycle accelerates.
InMode targeted in unsolicited bid; Morpheus8 users should monitor post-acquisition terms.
For practice owners, InMode's potential acquisition could reshape device financing, support infrastructure, and product roadmap. Morpheus8 has gained significant market share in RF microneedling, competing directly with Cutera's Evolve and Lumenis platforms. A change in ownership could affect pricing, lease terms, clinical training, and software updates. Practices should monitor the deal outcome and any post-acquisition changes to service agreements or upgrade costs. Consolidation often leads to price increases and reduced flexibility in device terms.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.